Skip to Content Skip to Search

GSK statement on recent media coverage related to our China business

Following media coverage this weekend, GSK has issued the following statement.

Issued: London UK

Following media coverage this weekend, GSK has issued the following statement:

"The issues relating to our China business are very difficult and complicated.

"The investigation by the Chinese authorities remains ongoing and we are co-operating fully with this investigation. Out of respect for the process we cannot comment on it at this time.

"We have zero tolerance for any kind of corruption in our business and we have many policies, procedures, controls in place to monitor this and we take action against any breaches.

"As we have said previously, the allegations that have been raised are deeply concerning to us. We have committed significant resources to find out what happened in China, including an independent legal review. We also continue to make fundamental changes to our business in China.

"We are learning lessons from this situation and we are determined to take all actions necessary as a result."

GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.